Aesculap v Shanghai Bojin Medical Instrument (CFI, 16 October 2026)
| Date | 16 October 2026 |
|---|---|
| Court | CFI |
| Division | Düsseldorf (DE) Local Division |
| Type of action | Infringement Action |
| Case number(s) | UPC_CFI_307/2025 |
| Registry reference | UPC_CFI_307/2025 |
| Parties | Aesculap AG v. Shanghai Bojin Medical Instrument Co. Ltd, Shanghai International Holding Corporation GmbH (Europe), Shanghai Bojin Electric Instrument & Device Co., Ltd |
| Language | German |
Official decision (PDF) · UPC registry entry
Case timeline
- 4 December 2025 : Aesculap v Shanghai Bojin Medical Instrument (CFI, 4 December 2025) UPC_CFI_307/2025
- 27 August 2026 : Aesculap v Shanghai Bojin Medical Instrument (CFI, 27 August 2026) UPC_CFI_307/2025
- 1 September 2026 : Aesculap v Shanghai Bojin Medical Instrument (CFI, 1 September 2026) UPC_CFI_307/2025
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 17 October 2026
Our analysis
Summary
By an order of 16 October 2026 (UPC_CFI_307/2025), the Düsseldorf Local Division dismissed Aesculap’s application to rectify its decision on the merits of 1 September 2026 concerning EP 2 892 442 B1. The claimant sought to turn the condition precedent attached to the measures ordered for the United Kingdom into a condition subsequent.
Question
Can the rectification procedure under Rule 353 RoP be used to change the nature of a condition attached to measures ordered by the Court?
Decision
The decision of 1 September 2026 had, among other things, granted an injunction against the second defendant for Germany, France and the United Kingdom. On 29 September 2026, Aesculap applied to rectify point I of the operative part and paras 125(a) and 126 of the grounds, relying on two Court of Appeal decisions. Filed within one month of service, the application was admissible (para. 7). It failed on the merits. Rule 353 RoP covers only clerical errors, errors in calculation and obvious slips, and the passages at issue reflect the Court’s intention, with no translation error (paras 8 and 9). Replacing ‘condition precedent’ with ‘condition subsequent’ would not in any case achieve the desired result, since the condition adopted by the Court of Appeal turns on the absence of a finding that the patent is invalid, and whether the decision is consistent with that case law is not a matter for rectification proceedings (paras 10 to 12).
Key points for practice
- Rectification cannot be used to revisit a deliberate choice made by the Court, even where Court of Appeal case law is invoked in support.
- A challenge on the merits to the conditions attached to the UK measures therefore cannot take this route, whatever the admissibility of the application.
Provisions applied
- Rules of Procedure
- Rule 353 RoP
- Case law cited
- Court of Appeal, UPC_CoA_312/2025, and Court of Appeal, 13 July 2026, Fujifilm v Kodak (UPC_CoA_473/2025), both relied on by the claimant
Related decisions
Prepared by Dhenne Avocats from the official decision, consulted on 17 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Going further
Lexicon: Patent infringement action, Multi-jurisdictional patent litigation.
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- German from the language of proceedings
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Parties
- claimantAesculap AG9 decisions in the corpusFollow this party
- defendantShanghai Bojin Medical Instrument Co. Ltd.3 decisions in the corpusFollow this party
- defendantShanghai International Holding Corporation GmbH (Europe)8 decisions in the corpusFollow this party
- defendantShanghai Bojin Electric Instrument & Device Co., Ltd.Follow this party
Decisions in the same proceedings and documented appeals
- 4 December 2025 Aesculap v Shanghai Bojin Medical Instrument (CFI, 4 December 2025) Generic Order · UPC_CFI_307/2025
L'audience est fixée au 17 juin 2026 et Shanghai Bojin Electric Instrument & Device est mise en cause. Une solution procédurale est proposée aux parties sur la restitutio et l'extension de l'action.
- 27 August 2026 Aesculap v Shanghai Bojin Medical Instrument (CFI, 27 August 2026) Infringement Action · UPC_CFI_307/2025
La division locale de Düsseldorf confirme la transaction entre Aesculap et deux défenderesses, laisse à chacune ses frais, ordonne la confidentialité des termes et poursuit l'instance contre la troisième.
- 1 September 2026 Aesculap v Shanghai Bojin Medical Instrument (CFI, 1 September 2026) Infringement Action · UPC_CFI_307/2025
La division locale de Düsseldorf juge que les deux fraises reproduisent la revendication 1 et retient la responsabilité d'intermédiaire, et non de contrefacteur, du mandataire européen du fabricant, à qui elle interdit ses services en Allemagne, en France et, sous condition, au Royaume-Uni.
- 16 October 2026 Aesculap v Shanghai Bojin Medical Instrument (CFI, 16 October 2026) Infringement Action · UPC_CFI_307/2025
What the record states
- Nature of the act
- Infringement Action
- Outcome (Dhenne Avocats summary)
- La division locale de Düsseldorf déclare recevable mais rejette la demande d’Aesculap tendant à rectifier la condition assortissant les mesures prononcées pour le Royaume-Uni.
- Appeal
- No appeal documented in the corpus, this does not mean that no appeal was lodged.
- Instance
- First-instance decision, whether it has become final is not recorded.
Patents mentioned
EP 2 892 442mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- Aesculap v Shanghai Bojin Medical Instrument (CFI, 1 September 2026) cited in this record
- Aesculap v Shanghai Bojin Medical Instrument (CFI, 27 August 2026) cited in this record
Patents and standards
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.